What are the side effects of entrectinib?
Entrectinibis suitable for the treatment of metastatic ROS1-positive non-small cell lung cancer in adults. Entrectinib is also indicated in adults and children 12 years of age and older for the treatment of NTRK gene fusion-positive solid tumors that have metastasized or where surgical resection may result in significant morbidity and have progressed on prior therapy or for which no comparable alternative therapies are available.

What are the side effects of entrectinib?
Elevated creatinine (73%), Anemia (67%), Hyperuricemia (52%), Fatigue (48%), Constipation (46%), < span>dysgeusia (44%), elevated transaminase (44%), edema ( 40%), Lymphopenia (40%), Elevated alanine aminotransferase (38%) , Hyponatremia (35%), Diarrhea (35%), Sensory disturbance ( 34%), Nausea (34%), Hypocalcemia (34%) span>, Hypophosphatemia (30%), Dyspnea (30%), Increased lipase (28%), Hypoalbuminemia (28%), Dizziness (28%) , Neutropenia (28%) , Myalgia (28%) , Cognitive impairment (27%
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)